Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TNFR1 inhibition with a Nanobody protects against EAE development in mice
Sophie Steeland, Sara Van Ryckeghem, Griet Van Imschoot, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Apoptotic cell death in disease—Current understanding of the NCCD 2023
Ilio Vitale, Federico Pietrocola, Emma Guilbaud, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 5, pp. 1097-1154
Open Access | Times Cited: 210
Selective Targeting of TNF Receptors as a Novel Therapeutic Approach
Roman Fischer, Roland E. Kontermann, Klaus Pfizenmaier
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 182
NANOBODIES®: A Review of Diagnostic and Therapeutic Applications
Bo-kyung Jin, Steven Odongo, Magdalena Radwanska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5994-5994
Open Access | Times Cited: 172
Tumor necrosis factor receptor-2 (TNFR2): an overview of an emerging drug target
Juliane Medler, Harald Wajant
Expert Opinion on Therapeutic Targets (2019) Vol. 23, Iss. 4, pp. 295-307
Closed Access | Times Cited: 145
TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond
Daniela Siegmund, Harald Wajant
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 9, pp. 576-591
Closed Access | Times Cited: 43
Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis
Maria Inês Cunha, Minhui Su, Ludovico Cantuti‐Castelvetri, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 5
Open Access | Times Cited: 120
A New Venue of TNF Targeting
Sophie Steeland, Claude Libert, Roosmarijn E. Vandenbroucke
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 5, pp. 1442-1442
Open Access | Times Cited: 117
Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments
Yoo Jin Jung, David Tweedie, Michael T. Scerba, et al.
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 113
Pathogenic T cell cytokines in multiple sclerosis
Catriona A. Wagner, Pamela J. Roqué, Joan Goverman
The Journal of Experimental Medicine (2019) Vol. 217, Iss. 1
Open Access | Times Cited: 98
Counteracting the effects of TNF receptor‐1 has therapeutic potential in Alzheimer's disease
Sophie Steeland, Nina Gorlé, Charysse Vandendriessche, et al.
EMBO Molecular Medicine (2018) Vol. 10, Iss. 4
Open Access | Times Cited: 96
Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity
Kamar‐Sulu N. Atretkhany, Ilgiz A. Mufazalov, Josefine Dunst, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 51, pp. 13051-13056
Open Access | Times Cited: 85
Neuron-specific activation of necroptosis signaling in multiple sclerosis cortical grey matter
Carmen Picón, Anusha Jayaraman, Rachel James, et al.
Acta Neuropathologica (2021) Vol. 141, Iss. 4, pp. 585-604
Open Access | Times Cited: 81
Re-Examining the Role of TNF in MS Pathogenesis and Therapy
Diego Fresegna, Silvia Bullitta, Alessandra Musella, et al.
Cells (2020) Vol. 9, Iss. 10, pp. 2290-2290
Open Access | Times Cited: 78
Insights into the biology and therapeutic implications of TNF and regulatory T cells
Benoı̂t L. Salomon
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 8, pp. 487-504
Open Access | Times Cited: 74
Transportation of Single-Domain Antibodies through the Blood–Brain Barrier
Eduardo Ruiz-López, Alberto J. Schuhmacher
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1131-1131
Open Access | Times Cited: 62
Cytokines, Vascular Endothelial Growth Factors, and PlGF in Autoimmunity: Insights From Rheumatoid Arthritis to Multiple Sclerosis
Young eun Lee, Seung‐Hyo Lee, Wan‐Uk Kim
Immune Network (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 11
Critical Role of Tumor Necrosis Factor Signaling in Mesenchymal Stem Cell-Based Therapy for Autoimmune and Inflammatory Diseases
Yan Li, Dejin Zheng, Ren‐He Xu
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 79
Central Nervous System Remyelination: Roles of Glia and Innate Immune Cells
Charbel S. Baaklini, Khalil S. Rawji, Greg J. Duncan, et al.
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 66
Distinct modes of TNF signaling through its two receptors in health and disease
Kamar‐Sulu N. Atretkhany, Violetta S. Gogoleva, Marina S. Drutskaya, et al.
Journal of Leukocyte Biology (2020) Vol. 107, Iss. 6, pp. 893-905
Closed Access | Times Cited: 59
Applications of nanobodies in brain diseases
Fang Zheng, Yucheng Pang, Luyao Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents
Huimin Zou, Ruixin Li, Hao Hu, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 56
Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosis
Sarah K. Williams, Richard Fairless, Olaf Maier, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 49
The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation
Fabian Richter, Sarah K. Williams, Katharina John, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 28
Recent progress and new challenges in modeling of human pluripotent stem cell-derived blood-brain barrier
Li Yan, Rebecca A. Moriarty, Kimberly M. Stroka
Theranostics (2021) Vol. 11, Iss. 20, pp. 10148-10170
Open Access | Times Cited: 28
Alcohol and multiple sclerosis: an immune system-based review.
Maryam Fahim, Aryan Rafiee Zadeh, Pouria Shoureshi, et al.
PubMed (2020) Vol. 12, Iss. 2, pp. 58-69
Closed Access | Times Cited: 28
Page 1 - Next Page

Scroll to top